South Dakota Politics Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on South Dakota Politics Today.

Press releases published on March 31, 2026

Mar. 31, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines – RGNX

Indeterminate GlobeNewswire

Mar. 31, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Sale of Masonite International Corporation Common Stock of Class Action Lawsuit and Upcoming Deadlines – DOOR

Indeterminate GlobeNewswire

Mar. 31, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Snowflake Inc. of Class Action Lawsuit and Upcoming Deadlines – SNOW

Indeterminate GlobeNewswire

Mar. 31, 2026

TBRG Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Indeterminate GlobeNewswire

Mar. 31, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Paysafe Limited of Class Action Lawsuit and Upcoming Deadlines – PSFE

Indeterminate GlobeNewswire

Mar. 31, 2026

BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

Indeterminate GlobeNewswire

Mar. 31, 2026

PYPL Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages PYPL Investors with Losses to Contact the Firm

Indeterminate GlobeNewswire

Mar. 31, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines – POM

Indeterminate GlobeNewswire

Mar. 31, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NuScale Power Corporation of Class Action Lawsuit and Upcoming Deadlines – SMR

Indeterminate GlobeNewswire

Mar. 31, 2026

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – BSX

Indeterminate GlobeNewswire

Mar. 31, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PayPal Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – PYPL

Indeterminate GlobeNewswire

Mar. 31, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Kyndryl Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – KD

Indeterminate GlobeNewswire

Mar. 31, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Oracle Corporation of Class Action Lawsuit and Upcoming Deadlines – ORCL

Indeterminate GlobeNewswire

Mar. 31, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines – QURE

Indeterminate GlobeNewswire

Mar. 31, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO

Indeterminate GlobeNewswire

Mar. 31, 2026

PLUG POWER CLASS ACTION DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. Urges Plug Power (NASDAQ:PLUG) Investors to Contact the Firm Before the Lead Plaintiff Deadline This Friday

Indeterminate GlobeNewswire

Mar. 31, 2026

Bragar Eagel & Squire, P.C. Urges Navan and Corcept Investors with Large Losses to Contact the Firm Before the Upcoming Lead Plaintiff Deadlines

Indeterminate GlobeNewswire

Mar. 31, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ultragenyx Pharmaceutical Inc. of Class Action Lawsuit and Upcoming Deadlines – RARE

Indeterminate GlobeNewswire

Mar. 31, 2026

Pomerantz Law Firm Announces the Filing of a Class Action Against ODDITY Tech Ltd. and Certain Officers – ODD

Indeterminate GlobeNewswire

Mar. 31, 2026

Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers – NKTR

Indeterminate GlobeNewswire